Filter
67
Filtered Results: 67
Text search:
Hallucinogens
Featured
Recommendations
3
New Publications
8
Language
Document type
No document type
50
Guidelines
9
Studies & Reports
4
Manuals
1
Situation Updates
1
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
Kenya
4
Western and Central Europe
4
Ukraine
2
Global
2
Sierra Leone
1
Nigeria
1
Africa
1
Latin America and the Carribbean
1
Eastern Europe
1
Moldova
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
4
Hepatitis
1
Pediatrics
1
Policies
1
Drugs & Medical Equipment
1
Studies & Reports
1
Statistics
1
General Guidelines
1
Non-communicable Diseases
1
HIV & STI
1
Toolboxes
Substance Use Disorders & Addiction
25
Substance Use Disorders, Others
18
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
9
Children/Adolescents Mental Disorders
9
HIV in Key Populations
6
Alcohol
4
Cannabis
4
Self-harm & Suicide
4
Diverse Chemical Substances
3
Others
3
Drugs
2
Schizophrenia
2
Men who have sex with men (MSM)
2
General Studies & Reports
2
Mental Health
2
People who injecting Drugs
2
Mental Health Guidelines
2
Mental Disorders
2
Disability Rights & Convention
1
Cocaine
1
TB & Drug Abuse
1
Preparedness, Response & Risk Communication
1
Ukraine
1
Training Manuals
1
Opoids
1
Eastern Europe
1
HIV
1
Latin America
1
Training
1
Mental Health Online Resources
1
Laboratory
1
Traditional & Herbal Medicines
1
Health Worker
1
Policies and guidelines
1
Bipolar Affective Disorders
1
Mental disorders, others
1
Testing Guidelines
1
TB/HIV Coinfection
1
Tobacco
1
Anxiety Disorders
1
Psychosocial Support
1
Depression
1
Reports & Studies
1
Eastern Europe and central Asia
1
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
Provides clinical descriptions, diagnostic guidelines, and codes for all mental and behavioural disorders commonly encountered in clinical psychiatry. The book was developed from chapter V of the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (...
The present booklet is about gender-responsive substance abuse treatment services for women. It is part of the United Nations Office on Drugs and Crime (UNODC) project to develop tools to support the development and improvement of substance abuse treatment services, based on evidence from the litera...
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the European context. The evidence is compiled following an explicit metho...
Mood disorders
Chapter E.4
2018 edition
Accessed: 28.03.2019
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Accessed: 21.03.2019
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
Substance use disorders
Chapter G.3
Roubles de l’humeur
Chapitre E.4
Edition en français Traduction : Cora Cravero Sous la direction de : David Cohen Avec le soutien de la SFPEADA
This report provides updated data on suicide in the Region of the Americas and is issued every five years, this being the fourth edition. In addition to including analysis similar to previous reports (suicide according to age, sex, as well as methods used), this report includes an expanded set of an...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
